Calvin Davis, DPM
Foot & Ankle Surgery · Renton, WANPI 1295225779
Payments from drug & device makers
What this record shows
14 manufacturers reported payments, led by Mid-atlantic Surgical Systems, LLC at 53.9% of the total. Reporting peaked in 2019 at $2,037 and has fallen 92.6% since, to $151 in 2025.
Across 48 payments — averaging $110.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mid-atlantic Surgical Systems, LLC$3K
- Stryker$1K
- Smith+Nephew$400
- Amgen$255
- Kerecis Limited$127
- Organogenesis Inc.$116
- plus $313 from 8 others
What the payments were for
- Food & beverage$2,47947%
- Education$2,81053%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mid-atlantic Surgical Systems, LLC | 7 | $2,849 |
| Stryker | 12 | $1,228 |
| Smith+Nephew | 13 | $400 |
| Amgen | 3 | $255 |
| Kerecis Limited | 2 | $127 |
| Organogenesis Inc. | 2 | $116 |
| Medical Device Business Services, Inc. | 1 | $112 |
| Treace Medical Concepts, Inc. | 2 | $48 |
| Advanced Oxygen Therapy Inc. | 1 | $42 |
| Johnson & Johnson | 1 | $35 |
| Bioventus LLC | 1 | $27 |
| Invictus Surgical Incorporated | 1 | $21 |
| Cardinal Health 200 LLC | 1 | $18 |
| Paratek Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VALOR$562
- RAYOS$370
- T2$306
- PROstep$256
- AUGMENT INJECTABLE$253
- ORTHOLOC 3DI$251
- ICONIX$231
- ANCHORAGE$146
- SONICANCHOR$124
- ORTHOLOC 3DI CROSSCHECK$117
- ORTHOLOC 2 LAPIFUSE$117
- NA$112
- Kerecis Omega3 Wound$111
- Kerecis Omega3 Surgibind$111
- Kerecis Omega3 GraftGuide$111
- Kerecis Omega3 SurgiClose$111
- FIXOS$107
- VARIAX$107
- G-FORCE$107
How this compares
$5,289 in reported general payments places this provider in the 70th percentile of 203 foot & ankle surgery providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Neomycin-Polymyxin-HydrocortNeomycin/Polymyxin B/Hydrocort | 22 | $1,081 |
| Diclofenac Sodium | 24 | $990 |
| Ciclopirox | 17 | $703 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 22 | $354 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 14 | $137 |
| Meloxicam | 58 | $94 |
| Oxycodone Hcl | 14 | $31 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Renton
- Shawn KhademiRenton$43K
- Christopher RobertsonRenton$8K
- Jeffrey ChristensenEverett$828K
- David DalstromSeattle$491K
- Richard LamourOlympia$87K
- Adam AlbabaSeattle$46K
- Stephen BenirschkeSeattle$45K
- Craig CliffordFederal Way$44K
- Gregory GrabowskiBellevue$34K
- Jacob McLeodLongview$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.